On Thursday, November 10, 2022, the BioHIve gathered at the Salt Palace for the annual BioHive Summit presented by Mayer Brown. It was the first time in three years the industry had gathered in person. The pent up demand for in-person networking combined with quality programming resulted in record registration of over 700 participants. Governor […]
PolarityTE provided a business update and reported financial results for the quarterly period ended September 30, 2022. […]
PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash. […]
Clene announced that it has entered into a securities purchase agreement with certain existing stockholders. […]
The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks Survival signal consistent with prior results […]
$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products. […]
Myriad Genetics announced financial results for its third quarter ended September 30, 2022 and provided an update on business performance. […]
Renalytix announced its full year results for the twelve months ended 30 June 2022. […]
Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022. […]
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022 […]
Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims for KidneyIntelX testing for patients with Medicare coverage. […]